Antibacterial Haemostatic Gels Market Players:
- Pfizer Inc.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- DEXX Laboratories Inc.
- Medura
- StopBleed
- Zoetis Inc
- Rapid-Seal
- Coloplast Group
- Gel-e-life sciences
- PREVESTDenPro
- Bio-Chem LLC
- Smith & Nephew
- Medtronic
- B. Braun SE
- 3M Company
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of antibacterial haemostatic gels is assessed at USD 1.66 billion.
The global antibacterial haemostatic gels market size was valued at around USD 1.57 billion in 2025 and is projected to grow at a CAGR of more than 6.3%, reaching USD 2.89 billion revenue by 2035.
By 2035, North America is anticipated to command a 43% share in the antibacterial haemostatic gels market, attributed to the expanding advancement of healthcare infrastructure in the region.
Key players in the market include Pfizer Inc., DEXX Laboratories Inc., Medura, StopBleed, Zoetis Inc., Rapid-Seal, Coloplast Group, Gel-e-life sciences, PREVESTDenPro, Bio-Chem LLC, Smith & Nephew, Medtronic, B. Braun SE, 3M.
